Herein we report the discovery of a series of new KDM5A inhibitors. A three-dimensional (3D) structure model of KDM5A jumonji domain was firstly established based on homology modeling. Molecular docking-based virtual screening was then performed against commercial chemical databases. A number of hit compounds were retrieved. Further structural optimization and structure-activity relationship (SAR) analysis were carried out to the most active hit compound, 9 (IC50: 2.3 μM), which led to the discovery of several new KDM5A inhibitors. Among them, compound 15e is the most potent one with an IC50 value of 0.22 μM against KDM5A. This compound showed good selectivity for KDM5A and considerable ability to suppress the demethylation of H3K4me3 in intact cells. Compound 15e could be taken as a good lead compound for further studies.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bmcl.2016.03.048 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Histone demethylase enzymes KDM5A and KDM5B modulate immune response by suppressing transcription of endogenous retroviral elements.
bioRxiv
September 2024
Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California.
Article Synopsis
- Epigenetic factors like KDM5A and KDM5B are linked to cancer and immune regulation, and researchers studied their impact on gene expression and chromatin structure by removing these proteins in cells.
- Analysis showed a drop in specific gene expressions (KRAB-ZNF genes) when KDM5A or KDM5B were absent, while inhibition of their demethylase activity did not affect these genes as expected.
- The study found that loss of KDM5A rapidly increases the expression of endogenous retroviruses, suggesting a role for KDM5A alongside the NuRD complex in controlling these viral elements, highlighting potential therapeutic strategies in targeting these proteins to enhance cancer treatments.
miR-96-5p expression is sufficient to induce and maintain the senescent cell fate in the absence of stress.
Proc Natl Acad Sci U S A
October 2024
Institute on the Biology of Aging and Metabolism, University of Minnesota, Minnesota, MN 55455.
Senescence is a cell fate driven by different types of stress that results in exit from the cell cycle and expression of an inflammatory senescence-associated secretory phenotype (SASP). Here, we demonstrate that stable overexpression of miR-96-5p was sufficient to induce cellular senescence in the absence of genotoxic stress, inducing expression of certain markers of early senescence including SASP factors while repressing markers of deep senescence including LINE-1 and type 1 interferons. Stable miR-96-5p overexpression led to genome-wide changes in heterochromatin followed by epigenetic activation of p16, p21, and SASP expression, induction of a marker of DNA damage, and induction of a transcriptional signature similar to other senescent lung and endothelial cell types.
View Article and Find Full Text PDFGenomic analysis reveals molecular characterization of CD30 and CD30 extranodal natural killer/T-cell lymphomas (ENKTLs).
Hum Pathol
October 2024
Department of Pathology, School of Basic Medical Sciences and Qilu Hospital, Shandong University, Jinan, China. Electronic address:
Article Synopsis
- Extranodal natural killer/T-cell lymphoma (ENKTL) is common in Asians, but its molecular characteristics are not well understood; this study focuses on CD30 expression and genetics of samples.
- CD30 was found to be positive in approximately 55.74% of ENKTLs, and significant mutations were noted in various genes related to cell function and cancer progression, highlighting the involved pathways.
- The study discovered higher BCL10 expression in ENKTL compared to normal tissues, suggesting that BCL10 inhibitors may offer a new treatment option for this type of lymphoma.
Identification of Proteolysis Targeting Chimeras (PROTACs) for Lysine Demethylase 5 and Their Neurite Outgrowth-Promoting Activity.
Chem Pharm Bull (Tokyo)
June 2024
Graduate School of Medical Science, Kyoto Prefectural University of Medicine.
Article Synopsis
- Lysine demethylase 5 (KDM5) proteins play a role in neurological disorders like Alzheimer's, and targeting them could be a therapeutic approach.
- Conventional KDM5 inhibitors are limited because they only affect the enzyme's activity, not its overall function.
- Researchers developed new compounds called PROTACs that degrade KDM5 proteins, leading to enhanced neurite growth in neuroblastoma cells, indicating their potential as drug candidates for treating neurological disorders.
KDM5A/B contribute to HIV-1 latent infection and survival of HIV-1 infected cells.
Antiviral Res
August 2024
Department of Pathology, College of Medicine, The Ohio State University, Columbus, OH, 43210, USA; Department of Microbial Infection and Immunity, College of Medicine, The Ohio State University, Columbus, OH, 43210, USA. Electronic address:
Combinational antiretroviral therapy (cART) suppresses human immunodeficiency virus type 1 (HIV-1) viral replication and pathogenesis in acquired immunodeficiency syndrome (AIDS) patients. However, HIV-1 remains in the latent stage of infection by suppressing viral transcription, which hinders an HIV-1 cure. One approach for an HIV-1 cure is the "shock and kill" strategy.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!